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Summary 
Although Pgs28, a 28-kD surface protein of Plasmodium gallinaceum o6kinetes, was previously 
thought not to be a target of transmission-blocking antibodies, we found that polyclonal antisera 
to Pgs28 completely blocked parasite infectivity to Aedes aegypti mosquitoes. Antisera raised against 
reduced Pgs28 were less effective in blocking transmission than were antisera to nonreduced Pgs28; 
thus, the target epitope(s) of transmission-blocking  antibodies appears to be conformation dependent. 
In stage-specific  assays, polyclonal antisera impaired the in vitro transformation of zygotes to 
mature o6kinetes,  as well as the in vivo development of mature o6kinetes to o6cysts.  Using 
microsequence of immunoaffinity-purified Pgs28, we cloned the 666-bp open reading frame of 
the Pgs28 gene. The deduced amino acid sequence of Pgs28  is strikingly similar to that of a 
P. gallinaceum  zygote surface protein, Pgs25, and its P. fakiparum  analogue, Pfs25.  Pgs28, like 
Pgs25 and Pfs25, has a presumptive secretory signal sequence, followed by four epidermal growth 
factor-like domains,  and a terminal hydrophobic region. 
ntibodies  to  surface proteins  of sexual  stage  malarial 
parasites  can  completely  inhibit  infectivity  to  the 
mosquito vector, and thus block transmission of malaria (1-4). 
A  series  of antigens, identified as targets of transmission- 
blocking antibodies, sequentially appear on the surface of the 
parasite as it develops in the mosquito midgut (3, 5, 6). Be- 
cause drug-resistant parasite strains and insecticide-resistant 
mosquitoes have rendered current control measures increas- 
ingly ineffective, several of these sexual stage antigens have 
become attractive candidates for a transmission-blocking vac- 
cine to control the spread of malaria (7). A combination of 
these transmission-blocking target antigens in a "cocktail" 
vaccine may elicit a more efficacious  immune response of 
greater duration and have broader immunogenicity than a 
transmission-blocking vaccine that consists of just a single 
antigen. 
Plasmodium gallinaceum is a facile model for the study of 
transmission-blocking vaccines and sexual stage antigens be- 
cause of its unique capability to undergo complete sporogonic 
development in vitro (8) and because of its phylogenetic prox- 
imity to P. fakiparum  (9,  10).  In particular,  the expression 
of surface proteins during the sexual stages of their life cycle 
is strikingly similar in P. gallinaceum  and P. fakiparum  (6). 
8 yr ago, Grotendorst et al.  (11) described a 28-kD P. gal- 
linaceum surface protein, Pgs28, that is immunoprecipitated 
from extracts of zygotes/o6kinetes by mAbs that suppress 
but do not block malaria transmission. Based on recent evi- 
dence that polyclonal sera to Pfs25,  a 25-kD transmission- 
blocking target antigen present on the surface of P.fakiparum 
zygotes, are qualitatively better than mAbs in blocking trans- 
mission (12), we evaluated whether polyclonal sera to Pgs28 
might be more potent blocking reagents than  the mAbs 
studied previously. Here we report that murine polyclonal 
sera against immunoaftinity-purified Pgs28 completely block 
parasite transmission. We also describe the deduced amino 
acid sequence of Pgs28, which places it in a family of sexual 
stage  antigens  with  epidermal  growth  factor  (EGF)-like 
domains. 
Materials and Methods 
Oi~kinete Antigens.  Purified P. gaUinaceum (isolate 8A) zygotes 
were prepared from parasitized blood of infected White Leghorn 
chickens and transformed in vitro into o6kinetes as previously de- 
scribed (13). Antigens were extracted with 50 mM Tris, 150 mM 
NaC1, 5 mM EDTA, 0.5% Triton X-100, 0.02% NAN3, pH 7.4. 
Purification ofPgs28.  Pgs28  was immunoafl~nity purified from 
o6kinete extracts using mAb IID2-B3B3 (11) covalently linked to 
protein A-Sepharose 4B beads (ImmunoPure  |  Kit; Pierce Chem- 
ical Co., Rockford, IL), eluted from the resin by electrophoresis 
in 50 mM NH4HCO3, 0.1% SDS for 4 h at 10 mA (14), and size 
fractionated  by SDS-PAGE (10% polyacrylamide  gel) in nonreducing 
or reducing conditions. Approximately 5 #g of Pgs28 was dec- 
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with  trypsin (15), and microsequenced (William Lane,  Harvard 
MicroChemistry, Cambridge, MA), and ,vl/xg was electroblotted 
onto polyvinylidene difluoride for NH2-terminal  sequence  (Dr. 
John Coligan, Biological Resources Branch, National Institutes of 
Health,  Bethesda, MD). 
Screening Genomic DNA Library.  Tryptic peptide sequences of 
Pgs28 were used to construct synthetic degenerate oligonucleotide 
probes. A genomic library of HindlII-digested P. gallinaceum DNA 
was constructed in pUCD. Filter-immobilized Escherichia  coli colo- 
nies were screened with 12 ng ofradiolabeled oligonucleotide probe 
NT14AGT." 5'-TT (AG)TT (AG)TC (TC)TT GTA TGG (AG)TC 
(TC)TC-3', by hybridization at 45~  for 16 h.  The filters  were 
washed at a final stringency of6x SSC (1 M sodium chloride, 0.1 M 
sodium citrate, pH 7.0), 0.1% SDS at 49~  for 5 min (16). Auto- 
radiography at  - 70~  for 4-16 h was performed to identify posi- 
tive colonies.  The complete sequence  of the open reading frame 
from both strands  of clone 9A1 was determined by the dideoxy- 
nucleotide terminator method. 
Nucleic Acid Blotting.  For Northern blots, total cellular RNA 
from 5  x  107 5-h-old P. gallinaceum zygotes was size fractionated 
per lane on a 0.8% agarose-formaldehyde  gel and blotted by capil- 
lary transfer to a nylon membrane (Nytran; Schleicher & Schuell, 
Inc., Keene, NH) (17). For Southern blots, 0.5 #g of  genomic DNA 
from P. gatlinaceum parasites was digested by one or more restric- 
tion endonucleases,  subjected  to electrophoresis through  a  1% 
agarose gel, and transferred to a nylon membrane (18). Filters were 
hybridized overnight at melting temperature (Tm) -  10~  with 
32p-labeled probes,  then  washed  with  6x  SSC,  0.1%  SDS  at 
Tm-  5~  for 5 min (Southern blots) or 7 min (Northern blots). 
Immunizations.  Immunoaffinity-purified, SDS-PAGE size-frac- 
tionated  Pgs28  in  polyacrylamide  gel  was  emulsified  in 
Monophosphoryl Lipid  A  +  Trehalose  Dimycolate (MPL  |  + 
TDM),  according  to  the  manufacturer's  protocol  (Ribi  Im- 
munoChem Research, Inc., Hamilton, MN). Male BALB/c mice, 
aged 4-6 wk, were immunized up to seven times intraperitoneally 
with 0.2 ml of the emulsion ("~1/~g of protein). The control group 
of mice received polyacrylamide gel, without antigen, emulsified 
in MPL  |  +  TDM adjuvant. 
ImraunoelectromicroscoFy.  Mature o6kinetes were prepared for 
electron microscopy by standard techniques (19) using mAb IID2- 
B3B3 and goat anti-mouse antibodies (EY Labs, Inc., San Mateo, 
CA) conjugated with colloidal gold (10-15  nm). 
Transmission-blocking  Assays.  The method of quantifying trans- 
mission-blocking antibodies in vitro has been previously described 
(11).  Briefly,  mosquitoes  were  fed  test  antibodies  mixed  with 
P. gallinaceum-parasitized material (either infected chicken blood 
or mature o6kinetes mixed with naive chicken blood) through an 
artificial membrane feeding apparatus.  Infectivity was measured 1 
wk after the infectious bloodmeal by counting the number of  o6cysts 
per  mosquito  midgut  of '~20  mosquitoes.  Two  endpoints  of 
transmission-blocking activity in test sera were analyzed:  the per- 
centage of mosquitoes in a batch that had one or more o6cysts on 
their midgut,  and the number of o6cysts per midgut.  Mosquito 
batches fed on immune sera were compared with those fed on con- 
trols.  The percentage of mosquitoes with o6cysts was compared 
by X  2 analysis. The number of o6cysts/midgut was compared by 
Wilcoxon's rank  sum analysis. 
Results and Discussion 
Pgs28 Is a Major Surface Protein of P. gallinaceum O~kinetes 
Distinct  from Pgs25.  Immunoelectron microscopy, using mAb 
IID2 B3B3, demonstrated the uniform and extensive distri- 
Figure  1.  Distribution of Pgs28 on the surface of mature o6kinetes. 
Immunogold labeling of Pgs28 with mAb IID2-B3B3 showed extensive 
distribution of  gold particles  over  the entire cell surface  of a whole mature 
orkinete (x 21,250). Detail of the cell membrane (a,  x 59,250) showed 
gold particles above the cell coat. 
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reduced (lane I) or reduced (lane 2) immunoaffinity-purified  Pgs28 was 
size fractionated  by a  10%  SDS-polyacrylamide gel  and  stained  with 
coomassie blue. mAb IID2-B3B3 recognized the dominant band at 34 kD 
(lane 1) by Western blot,  but failed to recognize a band in the reduced 
material  (Western blot data not shown).  On the left is molecular mass 
in kilodahons.  (B) Northern blot analysis of total  R,  NA obtained  from 
5-h-old P. gallinaceum  zygotes hybridized with a 23-mer oligonucleotide, 
bution of Pgs28 on the surface of the mature ofkinete (Fig. 
1), corroborating earlier biosynthetic work that showed that 
Pgs28 is the predominant surface protein of mature ofkinetes 
(5). Thus, Pgs28 is distinct from Pgs25, which achieves peak 
synthesis in the early hours after parasite fertilization (5). Pgs28 
and Pgs25 can also be differentiated by their apparent Mr on 
SDS-PAGE, as well as their specific  recognition by mAbs (11). 
By Western blot analysis (data not shown), Triton X-100 ex- 
tracts of ofkinetes depleted of Pgs28 by chromatography with 
mAb IID2-B3B3  (specific for Pgs28) were not depleted  of 
Pgs25 as assayed  by mAb IID2-C5I (specific for Pgs25). Fur- 
thermore, by Western blot analysis the immunoaffinity-purified 
Pgs28 (Fig. 2) was recognized by mAb IID2 B3B3 but not 
by mAb IID2-C5I (data not shown). 
Polyclonal  Sera Directed  against Pgs28 Completely Block Malaria 
Parasite Transmission and Act at More than One Stage in the Life 
Cycle.  mAbs to Pgs28 were previously shown to suppress 
the development  of ofcysts after an infectious  bloodmeal, 
decreasing infectivity (measured as geometric mean number 
either  completely  degenerate at nucleotide  position  no.  15 (lane I), or 
replaced with adenosine (lane 2),  cytosine (lane 3),  guanosine (lane 4), 
or thymidine (lane 5) only at that final position. On the right is molecular 
weight in kilobases. 
Table  1.  Transmission-blocking  Activity  of Sera from Immunized  Animals 
Mean  oocyst  Infectivity  Mosq.  infected/ 
Sample  number  (range)  (percent  of control)  mosq.  dissected 
Preimmune  39.2  (21-62)  4/4 
Anti-Pgs28  (IID7)  0  (0)  0  0/5 
Control  (IIDS)*  5.3  (0-30)  22/33 
Anti-Pgs28  (IID8)*  0.02  (0-1)  <0.01  1/41 
Anti-red.Pgs28  (IID8)*  3.2  (0-32)  60.4  8/30 
Control  (IID13)  10.5  (0-37)  10/15 
Anti-Pgs28  (IID13)  0  (0)  0  0/19 
Control  (VIID7)  13.0  (5-26)  6/6 
Anti-Pgs28  (VIID7)  0  (0)  0  0/20 
Control  (IID14)  5.0  (0-41)  4/10 
Anti-Pgs28  (IID8)  0  (0)  0  0/12 
Control  (IIDS)  33.5  (0-302)  17/20 
Anti-Pgs28  (IIDS)  4.2  (0-56)  12.5  7/21 
Anti-red.Pgs28  (IID8)  6.6  (0-28)  29.8  9/14 
Pooled sera from two to three BALB/c mice either before immunization (Preimmune),  after immunization with adjuvant  alone (Control), or with 
nonredueed  or reduced immunoaffinity-purified  Pgs28 in adjuvant  (Anti-Pgs28  or Anti-red.Pgs28,  respectivdy)  were mixed  with parasite-infected 
chicken blood.  Mosquitoes  were dissected after 6-8 d, and the numbers  of infected mosquitoes  and oocysts determined  as previously described (11). 
Each sample is identified by immunization number (Roman numeral) and the number of days (D) postimmunization (Arabic numerals).  Shown from 
five separate experiments  is the infectivity  calculated as the mean oocyst count of the test group divided by the mean  oocyst count of the control 
group fed at the same time (x 100). On the bottom, the ability of sera to inhibit  in vivo development  of ookinetes into oocysts was measured (11). 
The transmission blocking assay was performed as above, except that in vitro cultured ookinetes were used rather than parasite-infected chicken blood. 
* Combined results  from two separate experiments. 
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from Immunized Animals 
No.  of  Total  no.  Percent 
Sample  ookinetes  of parasites  transformation 
Control  156  373  41.8 
Anti-Pgs28  31  368  8.4 
Sera from mice immunized with adjuvant or Pgs28  (see Table  1) were 
diluted 1:8 to 1:10 in M199 media containing 3-5  ￿  106 purified P. gal- 
linaceum zygotes. The parasites were then allowed to transform into ma- 
ture ofkinetes overnight. Only completely elongated forms, and not retorts 
or round forms,  were counted  as o/bkinetes. Total number of parasites 
includes only sexual stage parasites; the rarely observed asexual stage para- 
site or chicken leukocyte was not included. The combined results of three 
separate experiments are shown. The differences observed in the percent 
transformation were statistically significant  (p <0.05)  in each of three 
separate experiments  by X  2 analysis. 
ofcysts/midgut) to 38-48% of control (11). In contrast, we 
found that after a single boost with immunoa~nity-purified 
Pgs28, BALB/c mice generated polyclonal, monospecific an- 
tisera with complete transmission-blocking activity. In fact, 
in five transmission-blocking assays, 85 mosquitoes received 
Pgs28 antisera, of which oly  a single mosquito was infected, 
and in that mosquito only a single ofcyst developed (Table 1). 
Polyclonal  antisera against Pgs28 impair at least two dis- 
tinct stages of parasite sexual development:  (a) the transfor- 
mation of zygotes to ofkinetes; and (b) the development of 
ofkinetes to ofcysts. During an overnight incubation in M199, 
P. gallinaceum zygotes readily transform into elongated ofki- 
netes.  The addition of Pgs28 antisera to the culture  media 
significantly reduced the proportion of parasites that under- 
went this in vitro transformation (Table 2). In vivo, ofkinetes 
traverse the midgut epithelium, then lodge beneath the basal 
lamina to develop into ofcysts. This development occurs even 
when mosquitoes are fed mature ofkinetes grown in vitro; 
however, the proportion of mosquitoes that develops ofcysts 
was significantly reduced when Pgs28 antisera rather than 
control sera were added to a bloodmeal containing mature 
ofkinetes (Table 1). The incubation of mature ofkinetes with 
Pgs28 antisera in vitro  did not induce parasite death  (data 
not shown). The clear superiority  of polyclonal antibodies 
over mAbs against Pgs28 and against Pfs25 (12) may repre- 
sent the combined result of multiple blocks in parasite devel- 
opment. These data also emphasize the limitations of using 
the now classical mAb approach to identify transmission- 
blocking target  antigens. 
Oligonucleotide Probes Used to Clone the Gene Encoding Pgs28 
Were Deduced  from the NH2-terminal Amino Acid Sequence of 
Pgs28  M-KIPSLYFFFFIQ 
Pgs25  MNMSTV---FLFIQ 
Pfs25  MNKLYSLFLFLFIQ 
Consensus  M  . k  .  . s  1  .  . F  . F  I Q 
N-terminal~ 
APSDDEP~KN 
K"LLK  SI~KE 
KVTVDTV~KD 
....  d..CK. 
I A  I  I  L  T  I A 
L  V  L  K  Y  I  N  S 
L  S  I K  Y  N  N  A 
￿9  .  i  ....  a 
G  Y  L  I  E  M  S  N  H  I  E~K~N  N  D  Y  V  L  T  N  R  Y  E ~E  P  K  N-  K 
G  F  L  I  Q  M  S  N  H  F  ElClN[ClN  P  G  F  V  L  T  S  E  S  T  E  N  K  V  E  - 
G  F  L  I  Q  M  S  G  H  L  E~C~K~C]E  N  D  L  V  L  V  N  E  E  T  E  E  KV  L  K 
G  ￿9 L  I  ￿9 MSnH.  ECkCnnd.VLtn.  .  . C  E  . K  .  . k 
-ANSLDKR  GDFSK  A---ISLNKRLT-  K  IDGYD  EESI  V  NE 
EKTVNKP  GDFSK  I  KIDGNPVSYA  K  NLGYDMVNNV  IPNE 
C  ......  nKpC.D..  .C  .......  Nk  ....  C.Cn.GY.  .  .e.  .Ci.  .E 
~N  Y  K  E~G  E  G  K~V  W  D  G  I  i 
KNFR  ESGK  VLDPK 
KNVT  GNGK  ILDTS 
C  ....  Cg.  GKCv.D... 
LK  TK  NET  K 
LK  LKENET  A 
CtL.C  ......  C.k 
~A~IPMJCJSJCJFI~IVPS~ENNNT  TI,G  T~. 
P  V  K  T  G  V~S~N  I G  KV  P  N  V  Q  D  Q  N  K  S  K  D  G  T  K 
e  .....  CSCnIGkV.  n  .  ednNkCtkdG.  Tk 
HDVYYM~GNDNSGSGSGGGGGGGNSPPPSSGNS 
TsQIy~DI~  l  ..........  ~DGYTFDK~E.AI~LI 
VDGIYK~D~-  KDGFIIDNESSI~T 
.d..Y.C  ..............  G  ......  ss... 
TLSLFNALN--  IVFLIAVI--YI  I* 
SFSLFNILNLSI  IFI  ISLIYFYI  I* 
AFSAYN  ILNLS  IMFILFSVCFFI  M* 
..  SIfN.LN..  I.  F.  i..  i..  y  I  i 
Figure 3.  Deduced  amino acid sequence of Pgs28 compared with that of Pgs25 and cPFs25. The sequences obtained from the NH2 terminus of 
the mature protein and from two tryptic peptides (NT14 and NT16) are shown as underlined, bold italics. The consensus sequence shown as uppercase 
letters is for those amino acid residues identical in Pgs28,  Pgs25  (19), and Pfs25 (15), and as lowercase letters for those residues identical in Pgs28, 
and Pgs25 or Pfs25.  The cysteine residues present in EGF-like domains are enclosed in boxes. 
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Pgs28 from crude o6kinete extract resulted in a predominant 
band of 34 kD on 10% SDS-PAGE (Fig. 2 A), which was 
electroblotted  onto  polyvinylidene  difluoride  for  NH~- 
terminal sequencing (Fig. 3). Reduction of disulfide bonds 
by treatment of the immunoaf~nity-purified material with 
3-mercaptoethanol caused Pgs28 to comigrate on SDS-PAGE 
with the small amount of mouse light chain that coeluted 
from the immunoaffinity column (Fig. 2 A). After blotting 
onto  nitrocellulose  membrane,  the  reduced protein  was 
digested with trypsin, and eluted peptides were separated by 
reverse-phase HPLC. Three tryptic peptides were sequenced, 
of which two (NT14 and NT16;  Fig. 3) were unique when 
screened in Swiss Prot (Release 17; Centre Medicale Univer- 
sitaire, Geneva, Switzerland),  and one was identical  with 
mouse antibody light chain. 
Completely degenerate oligonucleotide probes recognized 
a 1.5-kb transcript by Northern blot hybridization with total 
RNA from 5-h-old  zygotes (Fig. 2 B), but failed to detect 
the gene by either Southern blot hybridization with genomic 
digests or colony screening of existing cDNA and genomic 
libraries  (data  not  shown).  A  greatly enhanced signal by 
Northern blot analysis was obtained with guanosine at posi- 
tion 12 and thymidine at position 15 (Fig. 2 B). This probe 
(NT14AGT)  identified a 3.3-kb band on Southern blot hy- 
bridization of a HindlII digest ofP. gallinaceum  genomic DNA 
(data not shown), and subsequently identified a positive done 
(p9A1) in a library of HindlII-digested genomic DNA ligated 
into pUC13 (data not shown). 
The Deduced Amino Acid Sequence of Pgs28 Demonstrates 
Significant  Homology with Pgs25  and Pfs25.  The 666-bp open 
reading frame (GenBank accession no. M96886) within p9A1 
yielded a deduced amino acid sequence that contained all three 
of the Pgs28 peptides that were microsequenced (Fig. 3). The 
only misread occurred at deduced amino acid residue posi- 
tion 28 (sequenced as proline in the eighth position of the 
mature protein; deduced as cysteine 28 in p9A1) (Fig. 3). The 
homology between Pgs28 and both Pgs25 and Pfs25 (20) is 
striking: all three proteins contain a putative secretory signal 
sequence, then four EGF-like domains,  and finally a short, 
COOH-terminal hydrophobic region without a hydrophilic 
(cytoplasmic) tail. Even though attempts to cleave these pro- 
teins from the surface of sexual stage parasites with phospha- 
tidylinositol-specific phospholipase C (PI-PLC) have not yet 
been successful (data  not  shown),  the short  hydrophobic 
COOH terminus, along with previous data indicating that 
these proteins incorporate the appropriate lipids and glycans 
(5), strongly suggest that all three proteins are anchored to 
the cell membrane of the parasite by glycosylphosphatidyl- 
inositol  (GPI). 
The six-cysteine  motif of EGF-like domains shared between 
these proteins does not necessarily imply a shared function, 
as these domains have been recognized in a number of pro- 
teins with diverse functions (21), including transmembrane, 
extracellular matrix, and soluble, secreted proteins.  For ex- 
ample,  MSPI~9, the  19-kD  surface polypeptide on P. Jal- 
ciparum merozoites/rings,  is a malarial parasite antigen with 
EGF-like domains (22). As MSP1 is expressed solely in asexual 
stage parasites, its function is likely to be different than those 
of the sexual stage-specific proteins,  Pgs25 (and the P. Jal- 
cilmrum analogue,  Pfs25) and Pgs28. 
Besides structural  and biochemical characteristics, Pgs25, 
Pfs25, and Pgs28 share immunochemical characteristics as well. 
Transmission-blocking mAbs against this family of proteins 
with EGF-like domains recognize nonreduced, but not re- 
duced, parasite extracts. Further, as has been found with Pfs25 
(D. C. Kaslow, unpublished data), polyclonal sera raised against 
reduced Pgs28 have substantially  diminished transmission- 
blocking activity compared with that raised against  non- 
reduced Pgs28 (Table 1). Now that the amino acid sequence 
for Pgs28 has been deduced, it is clear that the target epi- 
topes of transmission-blocking  antibodies  in this family of 
sexual stage antigens  depend on proper disulfide bonding 
within EGF-like domains. 
In addition, in this family of proteins, polyclonal mono- 
specific antisera are qualitatively, and not just quantitatively, 
superior to mAbs in blocking infectivity  (12). The superi- 
ority of polyclonal sera could be accounted for by a mixture 
of antibodies whose greater a~nity and/or particular isotype 
render them more effective at blocking transmission.  Our 
results, however, suggest an alternative or at least complemen- 
tary explanation.  Polyclonal antisera impair more than one 
stage of parasite development, possibly by acting against more 
than one epitope,  some of which may confer stage-specific 
susceptibility to immune intervention. It appears that poly- 
clonal sera combine these stage-specific  effects to provide vastly 
improved transmission-blocking activity. Whether combining 
these antigens in a single cocktail vaccine will also markedly 
enhance and prolong transmission-blocking activity can now 
be addressed. 
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